GEODE CAPITAL MANAGEMENT, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$165,888,000
+6.2%
1,097,362
+2.4%
0.02%
+8.7%
Q2 2022$156,219,000
+31.1%
1,072,125
+6.7%
0.02%
+53.3%
Q1 2022$119,116,000
-10.1%
1,004,613
+4.5%
0.02%
-6.2%
Q4 2021$132,447,000
+1.5%
961,090
+2.4%
0.02%
-11.1%
Q3 2021$130,432,000
+47.1%
938,974
+2.8%
0.02%
+50.0%
Q2 2021$88,677,000
+58.9%
913,450
+11.9%
0.01%
+33.3%
Q1 2021$55,810,000
-11.6%
816,539
+10.9%
0.01%
-18.2%
Q4 2020$63,133,000
+40.2%
736,596
+6.3%
0.01%
+22.2%
Q3 2020$45,033,000
-6.2%
692,710
+5.5%
0.01%
-10.0%
Q2 2020$47,999,000
+132.5%
656,536
+8.2%
0.01%
+100.0%
Q1 2020$20,645,000
-63.4%
606,691
-41.4%
0.01%
-16.7%
Q4 2019$56,378,000
+161.1%
1,035,630
+100.1%
0.01%
+20.0%
Q3 2019$21,595,000
+4.0%
517,620
+9.2%
0.01%0.0%
Q2 2019$20,760,000
+2.5%
474,100
+20.5%
0.01%0.0%
Q1 2019$20,257,000
-22.5%
393,586
-44.4%
0.01%
+25.0%
Q4 2018$26,154,000
+157.3%
707,294
+161.3%
0.00%
+33.3%
Q3 2018$10,164,000
+1.6%
270,687
+7.0%
0.00%0.0%
Q2 2018$10,001,000
+118.8%
253,062
+42.6%
0.00%
+200.0%
Q1 2018$4,571,000
-1.6%
177,458
+3.1%
0.00%
-50.0%
Q4 2017$4,643,000
-17.8%
172,108
+13.8%
0.00%0.0%
Q3 2017$5,651,000
+37.1%
151,200
-8.3%
0.00%0.0%
Q2 2017$4,122,000164,9040.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders